Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.50
-0.05 (-0.14%)
Apr 20, 2026, 1:23 PM CST

Nang Kuang Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,5903,7674,1565,3836,4533,888
Market Cap Growth
-16.35%-9.36%-22.80%-16.59%65.97%-2.78%
Enterprise Value
3,9064,2034,4355,6816,6514,113
Last Close Price
35.5537.3039.3549.0856.7332.52
PE Ratio
14.7515.4117.0727.1318.3319.83
Forward PE
-17.9317.9317.9317.9317.93
PS Ratio
1.661.741.892.503.332.18
PB Ratio
1.441.511.722.262.681.74
P/TBV Ratio
1.451.521.722.272.681.74
P/FCF Ratio
19.2820.22-119.3623.449.71
P/OCF Ratio
7.748.128.9115.7117.486.99
EV/Sales Ratio
1.811.942.022.643.432.31
EV/EBITDA Ratio
8.168.799.0112.8913.399.49
EV/EBIT Ratio
13.2114.2214.3021.8620.6816.16
EV/FCF Ratio
20.9722.57-125.9824.1610.27
Debt / Equity Ratio
0.260.260.260.300.170.24
Debt / EBITDA Ratio
1.371.371.291.600.821.23
Debt / FCF Ratio
3.523.52-15.651.491.33
Net Debt / Equity Ratio
0.130.130.140.140.000.05
Net Debt / EBITDA Ratio
0.650.650.680.740.010.26
Net Debt / FCF Ratio
1.671.67-5.797.250.020.29
Asset Turnover
0.570.570.570.580.550.53
Inventory Turnover
1.931.931.971.751.631.61
Quick Ratio
0.670.670.630.590.760.72
Current Ratio
1.401.401.271.201.581.39
Return on Equity (ROE)
9.93%9.93%10.14%8.29%15.14%8.82%
Return on Assets (ROA)
4.84%4.84%5.06%4.37%5.73%4.75%
Return on Invested Capital (ROIC)
8.75%8.91%9.12%9.42%11.56%8.91%
Return on Capital Employed (ROCE)
10.70%10.70%11.60%10.10%12.60%10.80%
Earnings Yield
6.81%6.49%5.86%3.69%5.46%5.04%
FCF Yield
5.19%4.95%-1.40%0.84%4.27%10.30%
Dividend Yield
4.50%-4.07%4.08%4.05%5.54%
Payout Ratio
66.11%66.11%82.98%117.07%51.64%82.39%
Buyback Yield / Dilution
-0.02%-0.02%-0.10%0.08%0.01%-0.03%
Total Shareholder Return
4.48%-0.02%3.96%4.15%4.06%5.50%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.